Heart Failure: Therapeutic Updates

Therapeutic updates in heart failure management have revolutionized patient care. Novel treatments, such as angiotensin receptor-neprilysin inhibitors (ARNIs), sodium-glucose co-transporter-2 inhibitors (SGLT2 inhibitors), and cardiac resynchronization therapy (CRT), have shown remarkable benefits in reducing hospitalizations, improving symptoms, and prolonging survival. Continuous research aims to optimize therapeutic options and enhance outcomes for heart failure patients.

    Related Conference of Heart Failure: Therapeutic Updates

    June 27-28, 2024

    5th European Summit on Cardiology Research

    London, UK
    July 16-17, 2024

    13th World Heart Congress

    Paris, France
    August 08-09, 2024

    13th World Heart Congress

    London, UK
    September 16-17, 2024

    3rd Global Summit on Cardiology and Cardiac Surgery

    Paris, France
    September 19-20, 2024

    7th World Heart and Brain Conference

    London, UK
    September 19-20, 2024

    6th Annual Conference on Vascular Medicine

    London, UK
    October 17-18, 2024

    38th World Congress on Heart Diseases

    London, UK
    October 17-18, 2024

    8th Annual Heart Rhythm Conference

    Barcelona, Spain
    October 17-18, 2024

    3rd International Conference on Cardiology

    London, UK
    October 24-25, 2024

    11th International Conference on Interventional Cardiology

    Zurich, Switzerland
    December 10-11, 2024

    6th Euro Cardiology Congress

    Dubai, UAE
    February 24-25, 2025

    40th World Cardiology Conference

    London, UK

    Heart Failure: Therapeutic Updates Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in